Trades on 1 secondary market

Mirvie

Mirvie is a clinical-stage women's health company founded in 2018 and based in South San Francisco, California, pioneering the early prediction of pregnancy complications. Its proprietary RNA platform uses a simple maternal blood test and machine learning to read tens of thousands of molecular messa

emerging 15.0 / 100 0 APIs View provider profile →
CompanyHealthcareWomen's HealthPrenatalPregnancyDiagnostics

Mirvie is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.